nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Analysis of pre-treatment markers predictive of treatment benefit for the therapeutic cancer vaccine MVA-5T4 (TroVax)
|
Harrop, Richard |
|
2012 |
61 |
12 |
p. 2283-2294 |
artikel |
2 |
Analysis of pre-treatment markers predictive of treatment benefit for the therapeutic cancer vaccine MVA-5T4 (TroVax)
|
Harrop, Richard |
|
|
61 |
12 |
p. 2283-2294 |
artikel |
3 |
A naturally processed HLA-DR-bound peptide from the IL-9 receptor alpha of HTLV-1-transformed T cells serves as a T helper epitope
|
Kobayashi, Hiroya |
|
2012 |
61 |
12 |
p. 2215-2225 |
artikel |
4 |
Cancer/testis antigens expression and autologous serological response in a set of Brazilian non-Hodgkin’s lymphoma patients
|
Inaoka, Riguel J. |
|
2012 |
61 |
12 |
p. 2207-2214 |
artikel |
5 |
Cellular and cytokine-dependent immunosuppressive mechanisms of grm1-transgenic murine melanoma
|
Alb, Miriam |
|
2012 |
61 |
12 |
p. 2239-2249 |
artikel |
6 |
Chemotherapy broadens the range of tumor antigens seen by cytotoxic CD8+ T cells in vivo
|
Jackaman, Connie |
|
2012 |
61 |
12 |
p. 2343-2356 |
artikel |
7 |
Clinical safety and pharmacological profile of the HLA-DR antibody 1D09C3 in patients with B cell chronic lymphocytic leukemia and lymphoma: results from a phase I study
|
Schweighofer, Carmen D. |
|
2012 |
61 |
12 |
p. 2367-2373 |
artikel |
8 |
Combined immunotherapy with Listeria monocytogenes-based PSA vaccine and radiation therapy leads to a therapeutic response in a murine model of prostate cancer
|
Hannan, Raquibul |
|
2012 |
61 |
12 |
p. 2227-2238 |
artikel |
9 |
Effective modulation of CD4+CD25+high regulatory T and NK cells in malignant patients by combination of interferon-α and interleukin-2
|
Liu, Guangxian |
|
2012 |
61 |
12 |
p. 2357-2366 |
artikel |
10 |
Efficacy of adjuvant immunotherapy with cytokine-induced killer cells in patients with locally advanced gastric cancer
|
Shi, Liangrong |
|
2012 |
61 |
12 |
p. 2251-2259 |
artikel |
11 |
EGCG targeting efficacy of NF-κB downstream gene products is dictated by the monocytic/macrophagic differentiation status of promyelocytic leukemia cells
|
Vézina, Amélie |
|
2012 |
61 |
12 |
p. 2321-2331 |
artikel |
12 |
Identification of novel MAGE-A6- and MAGE-A12-derived HLA-A24-restricted cytotoxic T lymphocyte epitopes using an in silico peptide-docking assay
|
Akiyama, Yasuto |
|
2012 |
61 |
12 |
p. 2311-2319 |
artikel |
13 |
Induction of T cell responses and recruitment of an inflammatory dendritic cell subset following tumor immunotherapy with Mycobacterium smegmatis
|
Rich, Fenella J. |
|
2012 |
61 |
12 |
p. 2333-2342 |
artikel |
14 |
Mast cells impair the development of protective anti-tumor immunity
|
Wasiuk, Anna |
|
2012 |
61 |
12 |
p. 2273-2282 |
artikel |
15 |
Phase II trial of hu14.18-IL2 for patients with metastatic melanoma
|
Albertini, Mark R. |
|
2012 |
61 |
12 |
p. 2261-2271 |
artikel |
16 |
The new aspects of immunotherapy in prostate cancer
|
Ghanei, Mostafa |
|
2012 |
61 |
12 |
p. 2375-2376 |
artikel |
17 |
Using the allergic immune system to target cancer: activity of IgE antibodies specific for human CD20 and MUC1
|
Teo, Pearline Zhaoying |
|
2012 |
61 |
12 |
p. 2295-2309 |
artikel |
18 |
Vitamin D-binding protein-derived macrophage-activating factor, GcMAF, and prostate cancer
|
Bellone, Matteo |
|
2012 |
61 |
12 |
p. 2377-2378 |
artikel |